ASCO Annual Report Names Significant Clinical Research Advances Of Past Year
Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial
Tykerb Plus Herceptin Better Than Monotherapy, Study Says
Bisphosphonates May Reduce Recurrent Breast Cancer
Study Finds High-Risk Women Reluctant To Take Tamoxifen
Cervical Cancer Screening Can Be Done Later, Less Often
No Benefit For Cetuximab In Early-Stage Colon Cancer
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation